Definium Therapeutics (DFTX) Interest Coverage Ratio (2023 - 2026)
Definium Therapeutics (DFTX) reported Interest Coverage Ratio of 49.35 for Q1 2026, up 7.62% year-over-year from 45.86 in Q1 2025, and down 33.39% quarter-over-quarter from 37.0 in Q4 2025.
Definium Therapeutics (DFTX) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 4 years of Interest Coverage Ratio data on file, last reported at 49.35 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 49.35, up 7.62% year-over-year; the trailing twelve-month figure through Mar 2026 was 31.71 (up 31.75% YoY), and the FY2025 annual result was 30.24, up 33.57% from the prior year.
- Interest Coverage Ratio retreated to 49.35 in Q1 2026 per DFTX's latest filing, from 37.0 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 17.49 in Q2 2025 and troughed at 423.84 in Q3 2023.
- A 4-year average of 114.76 and a median of 49.48 in 2024 frame the typical range for Interest Coverage Ratio.
- On a YoY basis, Interest Coverage Ratio climbed as much as 91.95% in 2024 and fell as far as 44.63% in 2024.
- A 4-year view of Interest Coverage Ratio shows it stood at 34.21 in 2023, then slumped by 44.63% to 49.48 in 2024, then climbed by 25.24% to 37.0 in 2025, then slumped by 33.39% to 49.35 in 2026.
- Business Quant data shows DFTX's Interest Coverage Ratio at 49.35 in Q1 2026, 37.0 in Q4 2025, and 35.85 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - | -49.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.35 |
| Dec 31, 2025 | -37.00 |
| Sep 30, 2025 | -35.85 |
| Jun 30, 2025 | -17.49 |
| Mar 31, 2025 | -53.42 |
| Dec 31, 2024 | -49.48 |
| Sep 30, 2024 | -34.10 |
| Jun 30, 2024 | -52.48 |
| Mar 31, 2024 | -51.16 |
| Dec 31, 2023 | -34.21 |
| Sep 30, 2023 | -423.84 |
| Jun 30, 2023 | -379.01 |
| Mar 31, 2023 | -274.50 |